CD44 and breast neoplasm: Future in vitro studies with RGD-free HAGM cryogel-based tumor models could further elucidate the role of HA-mediated CD44 activation in breast tumor progression and metastasis and could investigate the specific variant of CD44 isoforms involved in CD44/HA-mediated signaling pathways.